Sarepta Therapeutics EPS Basic from Accounting Change (Quarterly) Insights

Sarepta Therapeutics, Inc. (SRPT)

18.63 +0.04 (+0.22%) USD | NASDAQ | Feb 20, 15:10

View EPS Basic from Accounting Change (Quarterly) for SRPT.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Basic from Accounting Change (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Basic from Accounting Change (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Basic from Accounting Change (Quarterly) Benchmarks

Start Trial

Arrowhead Pharmaceuticals, Inc.	--
Merck & Co., Inc.	--
Pfizer Inc.	--
Keros Therapeutics, Inc.	--
Alnylam Pharmaceuticals, Inc.	--